ARTICLE | Clinical News
Avelumab: Phase II data
May 23, 2016 7:00 AM UTC
Top-line data from 61 evaluable patients with metastatic MCC that has progressed following chemotherapy and who were followed for >=24 weeks in the open-label, international Phase II JAVELIN Merkel 20...